State WV
Clinical Trials in West Virginia
West Virginia is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in West Virginia and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in West Virginia
Frequently Asked Questions — Clinical Trials in West Virginia
How many clinical trials are currently recruiting in West Virginia?
ClinicalMetric currently tracks 49 actively recruiting clinical trials with at least one location in West Virginia. The total number of registered studies—including active but not currently enrolling trials—is 49. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in West Virginia?
West Virginia hosts clinical trials across a broad range of medical conditions, including Acute Ischemic Stroke, HIV Infections, Stage IIIB Lung Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout West Virginia serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in West Virginia?
To join a clinical trial in West Virginia, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in West Virginia maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in West Virginia
NCT04197921 N/A
Recruiting
Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and...
Condition
Opioid-use Disorder
Enrollment
29 pts
Location
United States
Sponsor
InSightec
NCT05361941 N/A
Recruiting
Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth In/n...
Condition
Periprosthetic Joint Infections
Enrollment
204 pts
Location
United States
Sponsor
Elute, Inc.
NCT07058077 Phase 2, Phase 3
Recruiting
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children a...
Condition
Heterozygous Familial Hypercholesterolemia (HeFH)
Enrollment
153 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT05828069 Phase 2
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapse...
Condition
Recurrent Langerhans Cell Histiocytosis
Enrollment
48 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT06776783 Phase 3
Recruiting
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syn...
Condition
Respiratory Distress Syndrome
Enrollment
520 pts
Location
United States
Sponsor
Aerogen Pharma Limited
NCT06065748 Phase 3
Recruiting
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestran...
Condition
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Enrollment
1,050 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT07103733 N/A
Recruiting
PRIMARY Ancillary Substudy
Condition
Mitral Valve Prolapse
Enrollment
250 pts
Location
United States, Germany, United Kingdom
Sponsor
Annetine Gelijns
NCT05204888 N/A
Recruiting
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Condition
COPD
Enrollment
642 pts
Location
United States, Canada
Sponsor
Temple University
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT01885299 N/A
Recruiting
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Condition
Neoplasms
Enrollment
50,000 pts
Location
United States
Sponsor
The Radiosurgery Society
NCT06631287 Phase 3
Recruiting
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSi...
Condition
Long COVID
Enrollment
550 pts
Location
United States
Sponsor
Wes Ely
NCT05946213 Phase 3
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in...
Condition
Prostate Adenocarcinoma
Enrollment
1,209 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT06988605 N/A
Recruiting
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe A...
Condition
Atopic Dermatitis
Enrollment
1,000 pts
Location
United States, Germany, United Kingdom
Sponsor
Galderma R&D
NCT05611242 Phase 3
Recruiting
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlu...
Condition
Acute Ischemic Stroke
Enrollment
404 pts
Location
United States
Sponsor
Mercy Health Ohio
NCT04628767 Phase 2, Phase 3
Recruiting
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for...
Condition
Renal Pelvis and Ureter Urothelial Carcinoma
Enrollment
131 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04613596 Phase 2, Phase 3
Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and...
Condition
Advanced Non-Small Cell Lung Cancer
Enrollment
626 pts
Location
United States, Argentina, Australia
Sponsor
Mirati Therapeutics Inc.
NCT05561387 Phase 3
Recruiting
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM)...
Condition
Plasma Cell Myeloma
Enrollment
510 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT07281430 N/A
Recruiting
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Tri...
Condition
Cervical Carcinoma
Enrollment
500 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06096844 Phase 3
Recruiting
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Ad...
Condition
Advanced Lung Non-Small Cell Carcinoma
Enrollment
304 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06764966 Phase 2
Recruiting
Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis
Condition
Decompensated Liver Cirrhosis
Enrollment
50 pts
Location
United States
Sponsor
CAMC Health System
NCT06810505 Phase 3
Recruiting
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease...
Condition
Chronic Migraine
Enrollment
420 pts
Location
United States, Canada, Denmark
Sponsor
AbbVie
NCT07443254 Phase 1, Phase 2
Recruiting
Prospective IR-led Sedation Feasibility
Condition
Anesthesia
Enrollment
40 pts
Location
United States
Sponsor
CAMC Health System
NCT05879926 Phase 3
Recruiting
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression...
Condition
Breast Cancer
Enrollment
3,960 pts
Location
United States, Canada, Colombia
Sponsor
NRG Oncology
NCT05046600 N/A
Recruiting
Registry of Arthrex Hand and Wrist Products
Condition
Ulnar/Radial Collateral Ligament Reconstruction
Enrollment
650 pts
Location
United States
Sponsor
Arthrex, Inc.
Page 2 of 2 — 49 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology